GR3004200T3 - - Google Patents

Info

Publication number
GR3004200T3
GR3004200T3 GR920400571T GR920400571T GR3004200T3 GR 3004200 T3 GR3004200 T3 GR 3004200T3 GR 920400571 T GR920400571 T GR 920400571T GR 920400571 T GR920400571 T GR 920400571T GR 3004200 T3 GR3004200 T3 GR 3004200T3
Authority
GR
Greece
Application number
GR920400571T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3004200T3 publication Critical patent/GR3004200T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR920400571T 1987-02-02 1992-03-31 GR3004200T3 (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (1)

Publication Number Publication Date
GR3004200T3 true GR3004200T3 (el) 1993-03-31

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920400571T GR3004200T3 (el) 1987-02-02 1992-03-31

Country Status (42)

Country Link
US (1) US5036099A (el)
EP (1) EP0277738B1 (el)
JP (1) JPS63201184A (el)
KR (1) KR900001422B1 (el)
CN (1) CN1022324C (el)
AP (1) AP52A (el)
AR (1) AR243182A1 (el)
AT (1) ATE73800T1 (el)
AU (1) AU587736B2 (el)
BG (1) BG51042A3 (el)
CA (1) CA1335590C (el)
CS (2) CS265250B2 (el)
CY (1) CY1775A (el)
DD (1) DD267490A5 (el)
DE (1) DE3869149D1 (el)
DK (1) DK44888A (el)
EC (1) ECSP941082A (el)
ES (1) ES2032955T3 (el)
FI (1) FI89598C (el)
GR (1) GR3004200T3 (el)
HK (1) HK132695A (el)
IE (1) IE60000B1 (el)
IL (1) IL85277A (el)
IN (1) IN171799B (el)
IS (1) IS1533B (el)
LV (1) LV10252B (el)
MA (1) MA21171A1 (el)
MY (1) MY102737A (el)
NO (1) NO170581C (el)
NZ (1) NZ223373A (el)
OA (1) OA08710A (el)
PH (1) PH26545A (el)
PL (1) PL149550B1 (el)
PT (1) PT86675B (el)
RO (1) RO105052B1 (el)
RU (1) RU2011381C1 (el)
SG (1) SG27994G (el)
SI (1) SI8810183A8 (el)
UA (1) UA25898A1 (el)
WO (1) WO1988005656A1 (el)
YU (1) YU46766B (el)
ZA (1) ZA88679B (el)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US5118703A (en) * 1988-10-18 1992-06-02 Pfizer Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
ES2075055T3 (es) * 1988-10-18 1995-10-01 Pfizer Profarmacos de 3-acil-2-oxindol-1-carboxamidas antiinflamatorias.
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
IL274383B2 (en) 2017-11-02 2024-03-01 Accurate Medical Therapeutics Ltd Catheter for embolization with integral filter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
GR850310B (el) * 1984-02-07 1985-06-05 Pfizer
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
GR850669B (el) * 1984-03-19 1985-07-25 Pfizer
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
MY102737A (en) 1992-09-30
EP0277738B1 (en) 1992-03-18
FI893647A0 (fi) 1989-08-01
RO105052B1 (en) 1994-12-01
YU18388A (en) 1989-10-31
CN1022324C (zh) 1993-10-06
IN171799B (el) 1993-01-09
SI8810183A8 (sl) 1996-08-31
PL270415A1 (en) 1988-12-08
NO170581B (no) 1992-07-27
IS1533B (is) 1994-01-28
HK132695A (en) 1995-09-01
CN88100555A (zh) 1988-08-17
AU587736B2 (en) 1989-08-24
PT86675B (pt) 1992-07-31
US5036099A (en) 1991-07-30
ECSP941082A (es) 1994-12-15
CS64888A2 (en) 1988-08-16
NO170581C (no) 1992-11-04
IE880269L (en) 1988-08-02
IE60000B1 (en) 1994-05-18
NO884329D0 (no) 1988-09-29
DK44888A (da) 1988-08-03
DD267490A5 (de) 1989-05-03
AP8800081A0 (en) 1987-11-01
CA1335590C (en) 1995-05-16
PT86675A (pt) 1988-03-01
PL149550B1 (en) 1990-02-28
IL85277A (en) 1994-02-27
JPH0576945B2 (el) 1993-10-25
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
UA25898A1 (uk) 1999-02-26
IL85277A0 (en) 1988-07-31
CY1775A (en) 1996-04-05
AP52A (en) 1989-09-16
FI89598B (fi) 1993-07-15
LV10252A (lv) 1994-10-20
OA08710A (fr) 1989-03-31
DK44888D0 (da) 1988-01-29
AU1116088A (en) 1988-08-04
NZ223373A (en) 1989-06-28
PH26545A (en) 1992-08-19
ATE73800T1 (de) 1992-04-15
ZA88679B (en) 1989-09-27
CS265250B2 (en) 1989-10-13
KR880009961A (ko) 1988-10-06
EP0277738A1 (en) 1988-08-10
FI89598C (fi) 1993-10-25
KR900001422B1 (ko) 1990-03-09
YU46766B (sh) 1994-05-10
IS3309A7 (is) 1988-08-03
RU2011381C1 (ru) 1994-04-30
MA21171A1 (fr) 1988-10-01
NO884329L (no) 1988-09-29
ES2032955T3 (es) 1996-07-16
BG51042A3 (en) 1993-01-15
DE3869149D1 (de) 1992-04-23
AR243182A1 (es) 1993-07-30
SG27994G (en) 1994-10-14
CS354191A3 (en) 1992-04-15
WO1988005656A1 (en) 1988-08-11

Similar Documents

Publication Publication Date Title
FR2617791B1 (el)
IN166898B (el)
IN168936B (el)
GR3004755T3 (el)
GR3006343T3 (el)
GR3006879T3 (el)
GR3007657T3 (el)
GR3007431T3 (el)
GR3004200T3 (el)
DE3866159D1 (el)
IN168912B (el)
GR3007660T3 (el)
FR2616965B1 (el)
DE3875765D1 (el)
GR3005542T3 (el)
DE3784067D1 (el)
FR2622959B1 (el)
GR3005524T3 (el)
DE3890751T (el)
IN169731B (el)
IN168517B (el)
IN168008B (el)
IN166960B (el)
GR3007126T3 (el)
IN166902B (el)